COVID-19 Ag Test For use by professionals and lay public alike

Humasis COVID-19 Ag Test

  • Testing is very simple, performed by a nasal swab or a nasopharyngeal swab followed by screening on a test device
  • Nasal/Nasopharyngeal swab: cl. sensitivity more than 95 %, cl. specificity 100,00 %
  • The test shows the same sensitivity and specificity for the UK, Brasil, South Africa, California and New York virus variants
  • Results are apparent between 15 to 20 minutes
  • Test are made in South Korea

Based on an exception for antigenic tests issued by the Ministry of Foreign Affairs pursuant to Section 4, Paragraph 8 of Government Decree No. 56/2015 Coll. The Humasis COVID-19 Ag Test can be used for self-testing by lay public. *

Authorized e-shop: www.vsenacovid.cz

Humasis Ag Tests can also be purchased at a regular pharmacy network,
where they are delivered through an Alliance Healthcare distributor

Authorized distributors: Novatin s.r.o., phone n. +420 724 510 412, eva.rysova@novatin.com
and Care Comm Pharm s.r.o., phone n.: +420 420 737 951 213, info@vsenacovid.cz, +420 608 848 496, niki.jankova@carecomm.cz

Humasis COVID-19 Ag Test

Product information


    Description

    Humasis COVID-19 Ag Test uses monoclonal antibodies specific to COVID-19 antigens to detect COVID-19 specific antigens in human nasal swab and nasopharyngeal swab specimens.

    The test results are more accurate because the test contains 2 antibodies - monoclonal antibody against SARS-CoV-2 nucleocapsid and monoclonal antibody specific to RBD against SARS-CoV-2 spike protein, most manufacturers use only one Ab.

    A nitrocellulose membrane strip in the device contains one test line and one control line. The test line is pre-coated with anti-mouse monoclonal antibody to SARS-CoV-2 nucleocapsid and RBD for detection of SARS-CoV-2 antigens, and the control line is coated with goat anti-mouse IgG.

    When the extracted swab specimen is added to the sample well, it will migrate to the conjugate pad, which contains conjugated antibodies conjugated with colloidal gold directed against the SARS-CoV-2 antigen. If the sample contains SARS-CoV-2 antigens, antigen-antibody-conjugate complex will be formed. The complex will continue to migrate across the membrane until it reaches the capture zone (test line) where the complex will bind to immobilized antibodies and form visible colored band in the test line. The sample will continue to move along the membrane until it reaches the control line where excess conjugate binds and produces a second visible line. This control line indicates that the sample has migrated across the membrane as intended and the test was performed properly.

    Based on an exemption for antigen tests issued by the MoH pursuant to Section 4, Paragraph 8 of Government Decree No. 56/2015 Coll.* 

    NOTICE FOR CUSTOMERS:

    As part of the testing, the customer is obliged to ensure that if a lay person has a positive antigen test the health service provider should be informed immediately to perform a confirmatory test.

    If the customer is interested, the distributor will provide training for the designated person.

    NOTICE TO THE LAY PUBLIC:

    Read the package leaflet carefully. Follow the procedure: TEST PROCEDURE - Nasal swab, and then Test method: Nasopharyngeal / nasal swab for proper collection and testing. Evaluate the result according to the INTERPRETATION OF RESULTS.

    If the antigen test performed is positive, inform the healthcare provider immediately to perform a confirmatory test. 

    Report any adverse event that occurs during the use of the product to the State Institute for Drug Control of any adverse event.

    * Valid until 30th of April, 2021

    Package contents

    • 25 tests/package
    • Test device packaged individually in aluminium pouch (25 tests/box)
    • Disposable test tube with extraction buffer (25 ea/box)
    • Filter cap (25 ea/box)
    • Sterilised swabs for specimen collection (25 ea/box)
    • Instructions for use (1ea)

    Parameters

    Storage:

    Temperature

    2-30 °C

    Expiration

    18 months

    Downloads

    Related products

    COVID-19 Flu Ag Combo Test – Humasis

    Humasis COVID-19/Flu Ag Combo Test is one step in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of SARS-CoV-2 antigens and influenza A/B antigens in nasopharyngeal swab specimen of suspected patients.

    Humasis COVID-19 IgG/IgM Test

    Humasis COVID-19 IgG/IgM test is one step in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibody of Novel Coronavirus (COVID-19) in human whole blood, plasma or serum.

    Information video

    Test Humasis COVID-19 Ag

    Watch the video with presentation of product packaging and its use.